Therefore, in this study, the AI model incorporating both combined clinicopathological variables and MRI features achieved a high AUC of 0.90 and demonstrated high sensitivity and specificity, outperforming the model using MRI-alone or clinicopathologic-alone for the prediction of recurrence of HER2-low breast cancer. This evidence concerns the gene ERBB2 and breast carcinoma.